| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 04/12/2011 | US7923436 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/07/2011 | WO2011039096A1 Drug fusions and conjugates with extended half life |
| 04/07/2011 | US20110082127 New injectable formulations containing progesterone |
| 04/07/2011 | DE10141652B4 Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung The transdermal therapeutic system based on polyacrylate pressure-sensitive adhesives having no functional groups and its use |
| 04/07/2011 | CA2774552A1 Drug fusions and conjugates with extended half life |
| 04/06/2011 | EP2305804A1 MonoPEGylated human growth hormone |
| 04/06/2011 | EP2305795A1 Method of collecting placental stem cells |
| 04/06/2011 | EP2305714A2 Anti-interferon-alpha subtypes antibodies |
| 04/06/2011 | EP2305694A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 04/06/2011 | EP2305679A1 Pyrazoline dione derivatives as nadph oxidase inhibitors |
| 04/06/2011 | EP2305648A1 Amide derivatives useful as glucokinase activators |
| 04/06/2011 | EP2305314A2 Remodelling and glycoconjugation of antibodies |
| 04/06/2011 | EP2305313A2 Remodelling and glycoconjugation of interferon-alpha (IFNa) |
| 04/06/2011 | EP2305312A2 Remodelling and glycoconjugation of follicle-stimulating hormone (FSH) |
| 04/06/2011 | EP2305311A2 Glycoconjugation of peptides |
| 04/06/2011 | EP2305308A1 Remedies for diseases to be applied to eye |
| 04/06/2011 | EP2305267A2 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| 04/06/2011 | EP2305233A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2305232A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2305231A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2305195A1 Drug delivery compositions for improved stability of steroids |
| 04/06/2011 | EP2303838A1 A new metformin glycinate salt for blood glucose control |
| 04/06/2011 | EP2303226A2 Sustained delivery of exenatide and other polypeptides |
| 04/06/2011 | EP2185510B1 New salts of bazedoxifene |
| 04/06/2011 | EP1370277B1 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
| 04/06/2011 | CN102000121A Cordyceps militaris oligopeptide composition as well as preparation method and use thereof |
| 04/06/2011 | CN102000078A Compound raloxifene hydrochloride tablets and preparation method thereof |
| 04/06/2011 | CN101087756B Peptidase inhibitors |
| 04/05/2011 | US7919513 Inhibitors of p38 |
| 04/05/2011 | US7919507 N-aroyl cyclic amines |
| 03/31/2011 | WO2011038207A1 Phosphorus-containing thyroid hormone receptor agonists and methods of use |
| 03/31/2011 | WO2011036651A1 Pyrazoline dione derivatives as nadph oxidase inhibitors |
| 03/31/2011 | WO2011015892A3 Novel crystal form of cdb - 4124 and proces s for the preparation thereof |
| 03/31/2011 | WO2011003870A3 Mini-pegylated corticosteroids, compositions including same, and methods of making and using same |
| 03/31/2011 | US20110077241 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 03/31/2011 | US20110077199 Growth hormone polypeptides and methods of making and using same |
| 03/31/2011 | US20110076284 Novel Modulators |
| 03/31/2011 | CA2770278A1 Pyrazoline dione derivatives as nadph oxidase inhibitors |
| 03/30/2011 | EP2302387A1 Therapeutic and diagnostic uses of antibody specificity profiles for insulin-dependent diabetes mellitus |
| 03/30/2011 | EP2301970A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/30/2011 | EP2301629A2 Anti-interferon-alpha antibodies |
| 03/30/2011 | EP2301570A1 Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated and conjugated antibodies, antibody combinations and fusion proteins |
| 03/30/2011 | EP2301553A1 Polynucleotide therapy |
| 03/30/2011 | EP2301552A1 Polynucleotide therapy |
| 03/30/2011 | EP2301549A1 Remedies for diseases to be applied to eye |
| 03/30/2011 | EP2300472A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/30/2011 | EP2300046A2 Super fast-acting insulin compositions |
| 03/30/2011 | EP2300041A2 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants |
| 03/30/2011 | EP0933354B1 Calcium receptor-active compounds |
| 03/30/2011 | CN101998989A Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone and/or vasopressin production or release |
| 03/30/2011 | CN101998854A Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cycklopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 03/30/2011 | CN101991566A Application of lariciresinol to preparing medicament for resisting autoimmune disease and graft rejection disease |
| 03/30/2011 | CN101041016B Medicine for curing pituitary adenoma and its preparation method |
| 03/29/2011 | US7915310 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 03/29/2011 | US7915308 Therapeutic methods and compositions involving isoflavones |
| 03/29/2011 | US7914778 Methods of treatment using IL-16 antagonist peptides |
| 03/29/2011 | CA2622798C 17.beta.-nitro-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2443672C Aryl and biaryl piperidines used as mch antagonists |
| 03/29/2011 | CA2435730C Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 03/24/2011 | WO2011034834A2 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same |
| 03/24/2011 | US20110071217 Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes |
| 03/24/2011 | US20110071197 Bis-aryl compounds for use as medicaments |
| 03/24/2011 | US20110071179 Macrocyclic inhibitors of jak |
| 03/24/2011 | US20110071139 Cycloalkyl Lactame Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 |
| 03/24/2011 | US20110071122 System for use by compounding pharmacists cists to produce hormone replacement medicine customized for each customer |
| 03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof |
| 03/23/2011 | EP2298776A1 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists |
| 03/23/2011 | EP2298769A1 Xanthin derivatives, their production and utilisation as medicine |
| 03/23/2011 | EP2298760A1 Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
| 03/23/2011 | EP2298357A1 Compositions and methods for regulated protein expression in gut |
| 03/23/2011 | EP2298355A2 Albumin fusion proteins |
| 03/23/2011 | EP2298354A2 Remodelling and glycoconjugation of interferon-beta |
| 03/23/2011 | EP2297177A1 C-ring-substituted pregn-4-ene-21,17-carbolactone, and pharmaceutical preparations comprising the latter |
| 03/23/2011 | EP2297100A1 Tetrahydrocyclopentaýb¨indole androgen receptor modulators |
| 03/23/2011 | EP2296638A2 Identification of a molecular signature for antipsychotics and serms |
| 03/23/2011 | EP1469878B1 Fgfr agonists |
| 03/23/2011 | EP1446101B1 Catheter injectable depot compositions and uses thereof |
| 03/23/2011 | EP1278748B1 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 03/23/2011 | CN101987865A Antagonist of luteinizing hormone releasing hormone (LHRH) containing hydantoin structure |
| 03/23/2011 | CN101987097A Use of equol for treating skin diseases |
| 03/23/2011 | CN101245002B Process for producing steady iodination vegetable oil, iodination vegetable oil fatty acid ethyl ester |
| 03/22/2011 | US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 03/22/2011 | US7910707 Anti-interferon-α antibodies |
| 03/22/2011 | CA2479363C Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 03/22/2011 | CA2471538C Pyrrolopyrimidines |
| 03/22/2011 | CA2376797C Administration of non oral androgenic steroids to women |
| 03/17/2011 | WO2011030929A1 Compound for inhibiting type 3 17β-hydroxysteroid dehydrogenase |
| 03/17/2011 | WO2011030927A1 Compound for inhibiting type-3 17β-hydroxysteroid dehydrogenase |
| 03/17/2011 | WO2011029547A2 Pregnane derivatives condensed in the 16, 17 position with an n-substituted isoxazolidine ring as anti-inflammatory agents |
| 03/17/2011 | WO2011029359A1 MEDICAMENTS CONTAINING 11β HYDROXYSTEROID DEHYDROGENASE 1 DOUBLE REGULATORS AND USES THEREOF |
| 03/17/2011 | US20110065768 Non-steroidal androgens compounds |
| 03/17/2011 | US20110065661 Pharmacoperones for correcting disease states involving protein misfolding |
| 03/17/2011 | US20110065635 Methods and compositions for modulating insulin regulation |
| 03/17/2011 | US20110065627 Transdermal delivery of medicaments with combinations of cetylated fatty fatty ester penetrant complexes |
| 03/17/2011 | US20110064806 Solid compositions comprising an oxadiazoanthracene compound and methods of making and using the same |
| 03/17/2011 | US20110064773 pharmaceutical compositions comprising a thyroid hormon and their therapeutic use |
| 03/17/2011 | US20110064762 Protein a compositions and methods of use |
| 03/17/2011 | US20110064757 Nucleic acid molecules and polypeptides for immune modulation |
| 03/17/2011 | US20110064720 Dietary Supplement Compositions and Methods of Making and Using the Same |